In addition, a number of peripheral blood-based biomarkers have been suggested, however the most compelling data have been obtained from analysis of cerebrospinal fluid (CSF) in which the ratio of Aβ/phosphorylated tau combined with total tau levels yielded a positive predictive value in terms of conversion from MCI to AD [36]. The gene discussed is MAPT; the disease is Alzheimer disease.